Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$19.76

52W Range

$16.66 - $22.76

50D Avg

$20.33

200D Avg

$20.00

Market Cap

$11.77B

Avg Vol (3M)

$286.39K

Beta

0.86

Div Yield

$0.64 (3.73%)

FMS Company Profile


Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NYSE

ADR

Yes

Country

DE

Employees

113,639

IPO Date

Sep 17, 1996

Website

FMS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 23Mar 23
Health Care Products€9.18M€14.92M
Health Care Services€3.83B€3.71B

Fiscal year ends in Dec 23 | Currency in EUR

FMS Financial Summary


Dec 23Dec 22Dec 21
Revenue€19.45B€19.40B€17.62B
Operating Income€1.50B€-258.36M€301.32M
Net Income€499.00M€673.40M€969.31M
EBITDA€3.44B€1.58B€1.93B
Basic EPS€1.70€1.15€1.66
Diluted EPS€0.85€1.15€1.66

Fiscal year ends in Dec 23 | Currency in EUR

Latest Earnings Call Transcripts


Q2 24Jul 30, 24 | 12:39 PM
Q1 24May 07, 24 | 2:53 PM
Q4 23Feb 21, 24 | 1:41 PM

Peer Comparison


TickerCompany
AIHAesthetic Medical International Holdings Group Limited
HCAHCA Healthcare, Inc.
SGRYSurgery Partners, Inc.
INNVInnovAge Holding Corp.
PNTGThe Pennant Group, Inc.
EHCEncompass Health Corporation
UHSUniversal Health Services, Inc.
ACHCAcadia Healthcare Company, Inc.
SEMSelect Medical Holdings Corporation
ADUSAddus HomeCare Corporation
ENSGThe Ensign Group, Inc.
THCTenet Healthcare Corporation